解读数据:临床试验应该如何改变您的临床实践?
Jamieson M O'Marr1, Theodore Miclau1, Saam Morshed2
1Orthopaedic Trauma Institute, Institute for Global Orthopaedics and Traumatology, Department of Orthopaedic Surgery, University of California, San Francisco, Zuckerberg San Francisco General Hospital, 2550 23rd Street, Building 9, 2nd Floor, San Francisco, CA 94110, United States.
Injury
|July 13, 2023
概括
医生可以使用WHOM标准 (谁,如何,结果,最小化偏差) 来有效评估新的医学文献. 这一框架有助于确保研究成果适用,并安全地纳入临床实践.
科学领域:
- 医学研究评估医学研究评估
- 临床实践指南 临床实践指南
- 基于证据的医学是基于证据的医学.
背景情况:
- 将科学文献应用于临床实践至关重要,但具有挑战性.
- 技术进步和复杂的临床试验增加了评估的难度.
- 医生需要一个结构化的方法来整合新的研究.
研究的目的:
- 介绍评估医学文献的WHO标准.
- 为骨科外科医生和医生提供有效的评估方法.
- 促进将新型研究纳入临床实践.
主要方法:
- 谁的标准涉及四个关键的评估步骤.
- 评估研究的人口相关性 (谁).
- 评估干预的可复制性 (如何).
- 分析结果的临床意义.
- 识别和评估偏见最小化策略.
主要成果:
- "WHO框架"为文学评价提供了一种系统的方法.
- 它使临床医生能够确定研究结果的适用性.
- 这些标准指导了对干预可行性和结果相关性的评估.
- 它强调了对偏见和错误缓解的批判性评估.
结论:
- 基于证据的实践需要定期评估新的文献.
- 根据WHO的标准,临床医生可以帮助导航实践变化的研究.
- 该框架通过知情决策支持安全和有效的患者护理.
相关概念视频
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:13Therapeutic Index
4.4K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.4K